A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
Crossref DOI link: https://doi.org/10.1007/s40119-020-00196-1
Published Online: 2020-08-17
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lanfear, David E.
Neaton, Kelsey R.
Lu, Chen
Liu, Yimeng
Dent-Acosta, Ricardo E.
Funding for this research was provided by:
Amgen
Text and Data Mining valid from 2020-08-17
Version of Record valid from 2020-08-17
Article History
Received: 15 July 2020
First Online: 17 August 2020